Objective: Growth hormone (GH) improves cardiac function in experimental models of heart failure and human dilated cardiomyopathy. However, the mechanism by which GH increases myocardial contractility is not entirely clear. Our aim was to examine the 21 effects of GH on cardiac function and cardiac sarcoplasmic reticulum Ca release channels (ryanodine receptors, RyR) in the hearts of UM-X7.1 cardiomyopathic hamsters during the development of heart failure. Methods: Experimental and healthy control hamsters were examined at the age of 20 weeks. Recombinant human GH (2 mg / kg / day, sc) or vehicle was then administered for 3 weeks. We examined (i) the in vivo left ventricular (LV) size and LV systolic function using transthoracic echocardiography, (ii) the density (B ) significantly between the experimental groups. In normal control hamsters, GH treatment with this dose did not significantly enhance LV systolic function or the density of RyRs. There was no significant difference in terms of the connective-tissue volume-fraction, myocyte size and capillary density between the GH-and vehicle-treated groups of UM-X7.1 hamsters. Conclusions: GH treatment may improve cardiac function by preserving the density of RyRs and enhancing cellular function in cardiomyopathic hamster hearts.
Introduction
tion could result from an alteration at any step in excitation-contraction coupling, from alterations in sarcoplas- 21 Chronic hypersecretion of growth hormone (GH) inmic reticulum (SR) Ca -release and -uptake functions, duces further growth of most organs and may contribute to and / or from alterations in the characteristics of the a modulation of cardiac function. Previous studies have myofibrillar apparatus itself. shown that, in normal rats, chronic hypersecretion of GH The Syrian cardiomyopathic hamster (BIO 14.6 strain or caused by implantation of a GH-secreting tumor is associ-UM-X7.1 strain) displays hereditary abnormalities in carated with an increase in the maximum isometric force of diac and skeletal muscle [15] . These strains develop a the left ventricular papillary muscle [23, 30, 31] . A modulahypertrophic form of cardiomyopathy resulting in a greatly tion of the force developed by papillary muscles contracthickened ventricular wall and septum. This hamster model provides a unique opportunity to study factors that might underlie the frequent involvement of the myocardium in libitum access to tap water. Recombinant human GH (1 human primary muscle disorders. Changes in the failing mg / kg twice a day) (Norditropin, Novo Nordisk A / S, myocardium of the myopathic hamster include a deficient Denmark) or vehicle was injected subcutaneously in both 1 1 production of cyclic AMP [39] , a decrease in Na , Kcardiomyopathic and normal hamsters for 3 weeks as ATPase [24] , a decrease in the function of the SR described previously [42] . Our choice of this dose of GH 1 21 [8, 27, 38] , an inhibition of the Na / Ca exchanger [26] , was based on a previous study [42] in which the results 21 excessive Ca accumulation [4, 19] , fibrosis [28] , high showed that this dose could produce a significant increase inorganic phosphate [18] , and a depressed phosphorylation in myocardial contractility in rats with cardiac dysfunction. potential [40] .
According to our previous report [34] , in the UM-X7.1 21 Cardiac SR has the ability to sequester Ca , and plays hamster at the age of 18-20 weeks, although the cardiac 21 a crucial role in the regulation of intracellular Ca . Ca (via Ca -ATPase) back into SR. Thus, the cardiac when the B value was almost equivalent with control max SR plays an important role in excitation-contraction couhamster. The care of the animals and the protocols used pling, and consequently, an abnormality of its functions conformed with the Guiding Principles in the Care and Use may result in the systolic and diastolic dysfunctions seen in of Animals and were in accord with guidelines laid down heart failure. Recently, we studied the alterations of by the Animal Ethics Committee of Yamaguchi University cardiac function and cardiac RyR density that occurred School of Medicine. The investigation conforms with the during the development of heart failure in UM-X7. 1 Guide for the Care and Use of Laboratory Animals cardiomyopathic hamster hearts [34] . Our study showed published by the US National Institutes of Health (NIH that the RyRs in the UM-X7.1 cardiomyopathic hamster Publication No. 85-23, revised 1985) . were preserved at both the hypertrophic stage and the early stage of heart failure (with a possibly compensatory increase in the level of protein expression), even though at 2.2. General protocols and study objectives this time the cardiac function already showed a tendency to be impaired. As heart failure advanced, the density of RyR To enable us to determine the left ventricular (LV) gradually decreased. dimension and assess the contractile state in vivo, transAlthough the effects of GH on cardiac function have thoracic echocardiography [21] was performed before and been studied in experimental heart failure [32] and in after 1,2, or 3 weeks treatment with GH or vehicle human idiopathic dilated cardiomyopathy [9] , the mecha-(echocardiograph model SSD-280, Aloka, Tokyo, Japan, nism by which GH increases myocardial contraction with a 7.5-MHz sector scan probe). For recording the function is not entirely clear. The goal of the present study echocardiogram, the animal was placed on its back under was to investigate the effects of GH on cardiac function mild anesthesia produced with pentobarbital sodium (15 and cardiac RyRs, which play an important role on the mg / kg, im) [32] . This relatively small dose of pentobarbiexcitation-contraction coupling mechanism, in cartal sodium did not affect the level of blood pressure, heart diomyopathic hamsters.
rate, or the state of respiration in either type of hamster at any stage [16] . The probe was gently placed in contact with the middle of the thorax through an ultrasound 2. Materials and methods transmission medium (Aquasonic 100, Parker Laboratories, Orange, NJ). M-mode echocardiograms at the papillary 2.1. Animals muscle level were then obtained, with guidance from two-dimensional long-axis images [10] , and recorded on Nineteen cardiomyopathic (UM-X7.1) hamsters (kindly an image printer (UP-500, Sony, Tokyo, Japan). We took provided by Dr. Lemanskie, SUNY Health Science Center, the LV end-diastolic diameter (LVEDd) as the widest, and Syracuse, NY, and inbred in our laboratory) and 15 sex-, the end-systolic diameter (LVESd) as the narrowest dimenand age-matched normal golden hamsters (control, Japan sion in the M-mode recording. From these measurements, SLC Inc., Hamamatsu, Japan) were used as experimental the LV fractional shortening (LVFS) was calculated using animals. Both the cardiomyopathic and normal hamsters previously reported formulas [16] . Assessment of both were housed 5 hamsters per cage in an air-conditioned inter-and intraobserver variability was performed accordroom with automatic 12-h day / 12-h night cycling in the ing to the method of Bland and Altman [3] . To determine Experimental Animal Facility of the Yamaguchi University interobserver variability, 36 M-mode tracings were photoSchool of Medicine. They were all maintained under copied, and LVEDd and LVESd were measured indepenidentical conditions on a normal laboratory diet with ad dently by two different observers (T. Ueyama and T.
Ohkusa). Another set of copies was measured (by T. phenylmethyl sulfonyl fluoride (PMSF), at pH 7.0. The Ueyama) for intraobserver variability.
homogenate was filtered through two layers of cheesecloth. At the age of 23 weeks (i.e., after 3 weeks administraProtein concentration was determined by the method of tion of GH), and after the echocardiographic examination Lowry et al. [22] , using bovine serum albumin as standard. was completed, the hamsters were given additional penAliquots of homogenate were frozen in liquid nitrogen and tobarbital sodium (30 mg / kg, im) and the chest was stored at -808C until used. quickly opened. The heart was excised from each hamster 3 and immersed in ice-cold 0.9% NaCl. Ca ), in each case with a concentration of [ H]ryanodine The hearts were immersion-fixed in 10% buffered (specific activity 68.3 Ci / mmol, DuPont, Boston, MA, formalin. Specimens for histological examination were USA) from within the range 0.6-20 nM. The reaction was obtained from each heart, cross slices being cut mid-way terminated by rapid filtration of 1 ml of the incubation between apex and base. The samples were embedded in mixture through a glass fiber filter (Whatman GF / C, paraffin and sections 4 mm thick were cut and stained.
Maidstone, UK) under reduced pressure. To minimize the Myocyte size was quantitatively evaluated in hematoxylinnonspecific binding component, each filter was immedieosin preparation by method previously described [33] .
ately washed with 5 ml of ice-cold buffer (25 mM Intramyocardial small arteries and capillaries were eximidazole, 1.0 M KCl, 1.103 mM CaCl , 0.95 mM EGTA, 2 amined as well. Especially, we quantitatively analyzed the at pH 7.4) and removed while under vacuum. After capillary density in preparations stained with hematoxylinaddition of 5 ml of scintillation fluid, the radioactivity was eosin: the number of the capillaries was counted that were counted in a scintillation counter with an efficiency of cut at the nuclear level of the endothelial cells in randomly |50% (LSC-5100, Aloka, Tokyo, Japan). Nonspecific selected ten high power fields (3400) from the transversebinding was determined in the presence of 2 mM unly sectioned myocardial area, and then calculated the labelled ryanodine. density per square millimeter. This method probably underestimates the capillary density. But we used it 2.7. Statistical analysis because it was possible to correctly identify capillaries even under a light microscope. The connective-tissue All data are presented as mean6standard deviation volume-fraction was assessed with the aid of Azan staining (SD). Comparisons were performed by two-way analysis [12] . Each field was transferred to a digitizing pad of variance with Scheffe's test. Differences were taken to connected to a cursor-computer assembly (NIH image be significant at p,0.05. 1.60). The connective-tissue volume-fraction was calculated as the sum of all the connective tissue areas divided by the sum of all connective tissue and muscle areas in all fields [37].
Results

Blood analysis 3.1. Somatic and cardiac growth
Blood samples were obtained at the time of sacrifice. Both UM-X7.1 and golden hamsters treated with GH Serum was prepared and frozen at 2208C for subsequent showed a significantly greater increase in body weight analysis. Human GH was measured in hamster serum by (BW) than vehicle-treated or untreated animals (Table 1) . ELISA, according to previously described methods [1] .
Moreover, the % change in BW of GH-treated UM-X7.1 hamsters was greater than that of GH-treated golden 2.5. Whole ventricle crude homogenate prepartion hamsters at both 1 (18 vs 6% increase, respectively) and 3 weeks (47 vs 26% increase, respectively). Although the 3 A crude homogenate for the [ H]ryanodine binding BW of golden hamsters was significantly greater at each assay was prepared as previously described, with some stage than that of UM-X7.1 hamsters, the value of bivenmodifications [36, 43] . The whole ventricular tissue was tricular-to-body weight ratio (calculated using wet weights) homogenized twice for 20s each time, using a Brinkmann was significantly higher in each UM-X7.1 group than that Polytron, in 20 mM Tris-maleate containing 0.3 M sucin the corresponding group of golden hamsters. After 3 rose, 0.1 M KCl, 5 mg / l leupeptin, and 0.1 mM weeks of treatment, a severe congestive heart failure Table 2 shows serial changes in LV significantly between UM-X7.1 and golden hamsters at dimensions and fractional shortening (FS) in UM-X7.1 and any stage, nor between vehicle-treated and GH-treated golden hamster groups. At baseline (20 weeks of age), groups. both LVEDd and LVESd were significantly greater in UM-X7.1 hamsters than those in the golden hamsters.
3.4. Morphology After 3 weeks (at 23 weeks of age), both LVEDd and LVESd in untreated UM-X7.1 hamsters were increased and The GH-treated and vehicle-treated UM-X7.1 hamster LV motion was reduced compared with baseline group, groups showed qualitatively similar morphological abnoralthough not significant (Table 2 ). In UM-X7.1 hamsters, malities (Fig. 3) . The most obvious feature was the there was no significant difference of LVEDd between disintegration of cardiomyocytes. This occurred either by vehicle-treated and GH-treated animals at 3 weeks treatmyofibrillar dissolution, leaving sarcolemmal remnants and ment stage. However, LVESd was slightly, although not occasionally a few nuclei, or by coagulation of the significantly, reduced and FS was significantly increased in sarcoplasm, which became substantial scarring throughout GH-treated group, compared with the vehicle-treated group the wall of both ventricles. The scar tissues often distributat 3 weeks treatment stage (Table 2) . On the other hand, ed parallel to the myocardial fascicular runnings, constitutamong the golden hamsters, the GH-treated group did not ing whirlpool-like figures. No active degenerative changes show significant changes in LVEDd, LVESd, or FS after 3 of myocytes were noted, but calcified fragments sequesweeks of treatment (Table 2) . GH treatment did not trated within scars were observed. produce significant alterations in heart rate in either UMMean myocyte size was similar among the groups (n55 X7.1 or golden hamsters ( 
Discussion
The major findings of this study were as follows: 1) recombinant human GH, given at 2 mg / kg / day for 3 weeks to cardiomyopathic hamsters suffering heart failure, significantly enhanced LV systolic function without any change of LVEDd, whereas the same dose of GH did not affect cardiac function significantly, and did not induce cardiac hypertrophy in age-matched golden (control) hamsters; 2) GH prevented the decrease in the density of cardiac SR ryanodine receptors (RyRs) that otherwise occurred during the development of heart failure in cardiomyopathic hamsters. The second of the effects may contribute to an improvement in cellular function and thus to the improvement in cardiac contractility known to occur with GH. To our knowledge, this is the first investigation that GH treatment can improve cardiac function in cardiomyopathic hamsters (which display a hereditary abnormality in both cardiac and skeletal muscle), and that GH treatment markedly attenuated the reduction of the density of cardiac RyRs in cardiomyopathic hamsters with congestive heart failure. The improvement in cardiac function might be secondary to an increase in myocardial contractility probably attributable to an enhancement of RyRs in damaged myocytes. cardiac SR RyRs in cardiomyopathic and healthy hamsters, For group data, see Table 2. and to determine whether such GH treatment might be beneficial or detrimental during the development of heart failure. Absolute biventricular weight increased with GH narrowings due to intimal or medial thickening, in any treatment (2 mg / kg / day) in normal control hamsters, groups. The capillary density (n55 in each group) was however the biventricular / body weight ratio remained 2 1199668 / mm in the group of UM-X7.1 hamsters at 20 within the normal range. In untreated and vehicle-treated 2 weeks of age, 1130649 / mm in the group of UM-X7.1 UM-X7.1 cardiomyopathic hamsters, a severe congestive hamsters at 23 weeks of age without GH treatment, and heart failure associated with significant cardiac hyper-2 1174663 / mm in the group of UM-X7.1 hamsters at 23 trophy could be detected. However, with GH treatment, weeks of age with GH treatment.
Effects of GH on cardiomyopathic and healthy hamster hearts
there was no significant increase in biventricular weight There was no significant difference in terms of the when normalized with respect to body weight. These for the increased ventricular mass [13, 20, 35] . On the other Ca influx through L-type Ca channels. This could hand, in studies of animal models, histological examination explain, at least in part, the enhanced myocardial contrachas excluded an increase in interstitial tissue as a major tility. In addition, chronically high circulating GH levels component of the cardiac growth [2, 5, 7, 11] . In our study, have been found to induce a myosin phenoconversion the connective-tissue volume-fraction did not differ beconsisting of a marked shift toward the low ATPasetween the GH-, and vehicle-treated groups. Moreover, activity V isoform [23, 30] . Recently, Yang et al. [42] have 3 there was no significant difference in the connective-tissue reported that the reduction in afterload that forms part of volume-fraction, which was measured before or after the hyperkinetic state was also a beneficial effect of GH in treatment. These results indicate that, in UM-X7.1 carheart failure. Although GH excess would seem to evoke a diomyopathic hamster hearts, the degenerative changes unique pattern of myocardial responses with a simultahave subsided by 20 weeks of age and that calcified neous improvement in both force and economy of contracfragments are sequestered within scar tissue in consistent tion, few studies have been made of the involvement of the 21 21 with Jasmin's report [18] , and that GH treatment at this Ca -regulatory proteins (RyR, Ca -ATPase, calsequesdose (2 mg / kg / day) was not acting to prevent structural trin, etc.) of the SR, which play a crucial role in the 21 damage and / or to enhance tissue repair. We suspect that regulation of intracellular Ca . Recently, we reported GH may have direct effects on cellular metabolism with a that, in the UM-X7.1 cardiomyopathic hamster, the cardiac prompt stimulation of protein anabolism and a diversion of RyRs were preserved at both the hypertrophic (6-8 weeks amino acid from oxadative to protein synthetic pathways of age) and early stages of heart failure (18-20 weeks of [6, 14] by improving the function of compromised cardiac age) with a possibly compensatory increase in the level of myocytes or by tending to prevent further functional protein expression; however, the B of these RyR max decline. Our data, which indicate no difference in the decreased significantly during the development of the connective-tissue volume-fraction as a consequence of congestive heart failure [34] . In the present study, GH GH-treatment, is not consistent with the results of GH treatment largely prevented the decrease otherwise seen in hypersecretion on human hearts [13, 20, 35] . The following the B of the cardiac RyR in UM-X7.1 hamsters. This max 21 may explain this inconsistency: 1) we used a moderate might contribute to an alteration in Ca handling and play 21 dose of GH [5] for short duration (3 weeks), 2) the a part in increasing the amount of intracellular Ca UM-X7.1 hamsters were treated with GH from the age of available to activate the myofilaments, which would in turn 20 weeks, by which time the degenerative changes had alter cardiac contractility. We suspect that GH activates subsided and calcified fragments were sequestered within protein synthesis [6, 14] in the cardiomyopathic hamster scar tissue. heart and thus limits or prevents the decrease in the number of cardiac RyRs that occurs in the non-GH-treated 4.2. Mechanisms by which GH might increase animal. myocardial contractility 4.3. Conclusions The short-term effects of an excess of GH on the heart produce a hyperkinetic state characterized by high cardiac Treatment with a moderate daily dose of GH for 3 output and decreased peripheral vascular resistance [29] .
weeks improved cardiac function, at least in part, by There have been some reports proposing the mechanisms preserving the density of RyRs in the cardiomyopathic by which GH might increase myocardial contractility. For hamster heart. We could not evaluate the long term effect instance, studies with a GH-excess model have demonof GH on cardiomyopathic hamster hearts because adstrated improved contractile performance and a significant ministration of human GH for a longer period (more than 3 21 increase in the Ca sensitivity of the contractile proteins weeks) leads to the production of antibodies against human [23, 30] . Interestingly, GH excess also produced a pro-GH in hamsters. For example, we found that the serum longed action potential [41] , which in turn may facilitate human GH level decreased from 17966550 ng / ml after 3 No active degenerative changes of myocytes were noted, but calcified fragments sequestrated within scars were observed. These findings were consistent with the previous report [18] . Note that there was no apparent difference in severity and extent of the myocardial lesions among the hearts of 20-week-old (A), vehicle-treated 23-week-old (B) and growth hormone (GH)-treated 23-week-old cardiomyopathic hamster (C). Bar52.0 mm.
heart: a clinical and pathological study. Ann Intern Med weeks administration (see Table 1 ) to 3656175 ng / ml 
